Bank of America Corp DE decreased its holdings in The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) by 6.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 347,934 shares of the company's stock after selling 25,046 shares during the quarter. Bank of America Corp DE owned 0.60% of The Ensign Group worth $70,109,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company's stock worth $20,956,000 after purchasing an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in The Ensign Group by 150.3% during the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company's stock worth $50,000 after buying an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in The Ensign Group by 65.9% during the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company's stock worth $83,000 after buying an additional 213 shares in the last quarter. Amundi raised its position in The Ensign Group by 480,216.7% in the 2nd quarter. Amundi now owns 57,638 shares of the company's stock valued at $8,583,000 after buying an additional 57,626 shares during the last quarter. Finally, Brown Advisory Inc. raised its position in The Ensign Group by 26.1% in the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company's stock valued at $314,000 after buying an additional 421 shares during the last quarter. 96.12% of the stock is owned by institutional investors.
The Ensign Group Stock Up 0.5%
The Ensign Group stock opened at $183.94 on Tuesday. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00. The firm has a 50 day moving average price of $167.02 and a 200-day moving average price of $184.03. The company has a market capitalization of $10.72 billion, a P/E ratio of 28.83, a P/E/G ratio of 1.76 and a beta of 0.68. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06.
The Ensign Group (NASDAQ:ENSG - Get Free Report) last posted its quarterly earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, topping analysts' consensus estimates of $1.80 by $0.12. The company had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The Ensign Group's revenue was up 16.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. As a group, equities analysts predict that The Ensign Group, Inc. will post 6.93 EPS for the current year.
The Ensign Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.26 annualized dividend and a yield of 0.1%. The Ensign Group's dividend payout ratio is 4.08%.
Insider Buying and Selling
In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total transaction of $114,996.00. Following the sale, the director owned 21,352 shares of the company's stock, valued at $3,507,706.56. The trade was a 3.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the sale, the director directly owned 9,503 shares in the company, valued at $1,625,583.18. This trade represents a 3.96% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on ENSG. Weiss Ratings downgraded shares of The Ensign Group from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday, June 16th. Truist Financial increased their target price on shares of The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a report on Thursday, July 30th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday, July 28th. Finally, Wall Street Zen downgraded The Ensign Group from a "buy" rating to a "hold" rating in a research note on Saturday, July 25th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $216.25.
Get Our Latest Report on ENSG
About The Ensign Group
(
Free Report)
The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company's model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.
Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.
Read More
Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider The Ensign Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Ensign Group wasn't on the list.
While The Ensign Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report